NDUFS5 — NADH:Ubiquinone Oxidoreductase Core Subunit S5

NDUFS5 — NADH:Ubiquinone Oxidoreductase Core Subunit S5

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NDUFS5</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NDUFS5</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NADH:Ubiquinone Oxidoreductase Core Subunit S5</td>
</tr>
<tr>
<td class="label">Alias</td>
<td>15 kDa subunit, CI15</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1p33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4723</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000168653</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>603835</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O43920</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Complex I accessory subunits</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), Leigh Syndrome, Mitochondrial Complex I Deficiency, [Alzheimer's Disease](/diseases/alzheimers-disease)</td>
</tr>
</table>

NDUFS5 (NADH:Ubiquinone Oxidoreductase Core Subunit S5)

Overview

NDUFS5 — NADH:Ubiquinone Oxidoreductase Core Subunit S5

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NDUFS5</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NDUFS5</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NADH:Ubiquinone Oxidoreductase Core Subunit S5</td>
</tr>
<tr>
<td class="label">Alias</td>
<td>15 kDa subunit, CI15</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1p33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4723</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000168653</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>603835</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O43920</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Complex I accessory subunits</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), Leigh Syndrome, Mitochondrial Complex I Deficiency, [Alzheimer's Disease](/diseases/alzheimers-disease)</td>
</tr>
</table>

NDUFS5 (NADH:Ubiquinone Oxidoreductase Core Subunit S5)

Overview

NDUFS5 (NADH:Ubiquinone Oxidoreductase Core Subunit S5), also known as the 15 kDa subunit or CI-15, encodes an accessory subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase), the largest enzyme of the mitochondrial electron transport chain [[brandt1999]](https://pubmed.ncbi.nlm.nih.gov/10348884/). Located on chromosome 1p33, NDUFS5 plays a structural role in complex I assembly and function, and its dysfunction contributes to neurodegenerative processes including Parkinson's disease (PD) and Alzheimer's disease (AD) [[schapira2010]](https://pubmed.ncbi.nlm.nih.gov/20063447/).

Mitochondrial complex I (NADH dehydrogenase) is the first enzyme of the mitochondrial electron transport chain, catalyzing the oxidation of NADH and the reduction of coenzyme Q10 (ubiquinone). This pumping action establishes the proton gradient that drives ATP synthesis. Complex I dysfunction is a hallmark of PD, with selective loss of complex I activity in the substantia nigra of PD patients [[liu2011]](https://pubmed.ncbi.nlm.nih.gov/33498765/).

Function

Complex I Architecture

Mitochondrial complex I (NCI) is the largest oxidative phosphorylation complex, consisting of 44 different subunits [[janssen2006]](https://pubmed.ncbi.nlm.nih.gov/16257245/):

• 7 Core (FMN-containing) subunits: Form the catalytic core
• 13 Iron-sulfur (FeS) clusters: Enable electron transfer
• 31 Accessory subunits: Structural stability and assembly

Core Functions of NDUFS5:

• Complex I assembly: Essential for proper assembly of the Q-binding module [[distelmaier2009]](https://pubmed.ncbi.nlm.nih.gov/19362702/)
• Electron transfer: Facilitates electron transfer within the complex
• Structural stability: Contributes to the overall architecture of complex I
• Substrate binding: Assists in NADH and CoQ binding
• Proton pumping: Cooperates with core subunits for proton translocation

Catalytic Mechanism

Complex I catalyzes two coupled reactions:

NDUFS5 participates in these processes by:

• Stabilizing the Q-binding site
• Maintaining proper Fe-S cluster configuration
• Ensuring coupling between electron transfer and proton pumping

Normal Functions in Neurons

In neurons, complex I is critical for [[chang2014]](https://pubmed.ncbi.nlm.nih.gov/24726842/):

Energy Production

• ATP generation for ion homeostasis
• Maintenance of membrane potentials
• Neurotransmitter synthesis and release
• Synaptic function and plasticity

• Reactive oxygen species (ROS) as signaling molecules
• Calcium handling and mitochondrial calcium uptake
• Metabolic regulation through ATP/ADP ratios

• Apoptosis regulation
• Autophagy and mitophagy initiation
• Response to cellular stress

Role in Neurodegenerative Diseases

Parkinson's Disease

NDUFS5 is strongly implicated in PD [[gandhi2009]](https://pubmed.ncbi.nlm.nih.gov/19164459/):

Disease Mechanisms:

• Complex I deficiency: 30-40% reduction in complex I activity in substantia nigra
• Electron transport defects: Impaired NADH oxidation and CoQ reduction
• ROS overproduction: Increased superoxide radical formation
• Dopaminergic neuron vulnerability: Selective sensitivity to energy failure
• Alpha-synuclein toxicity: Mitochondrial dysfunction induced by alpha-synuclein aggregation [[guo2013]](https://pubmed.ncbi.nlm.nih.gov/23706211/)

• NDUFS5 polymorphisms: Associated with increased PD risk
• Compound heterozygosity: Multiple rare variants cause manifests disease
• Mitochondrial DNA interactions: Synergistic effects with mtDNA mutations [[perier2013]](https://pubmed.ncbi.nlm.nih.gov/23595257/)

• Coenzyme Q10 supplementation
• Nicotinamide riboside (NAD+ precursor)
• Mitochondria-targeted antioxidants [[wang2022]](https://pubmed.ncbi.nlm.nih.gov/34976123/)
• Gene therapy approaches

Alzheimer's Disease

Complex I dysfunction is also observed in AD [[moreno2019]](https://pubmed.ncbi.nlm.nih.gov/31782876/):

• Amyloid-beta effects: Direct inhibition of complex I
• Tau pathology mitochondrial dysfunction: Cross-talk between tau and complex I
• Glucose hypometabolism: Correlates with complex I dysfunction
• Neuronal bioenergetic crisis: Progressive energy failure

Leigh Syndrome

NDUFS5 mutations cause classic Leigh syndrome [[koene2012]](https://pubmed.ncbi.nlm.nih.gov/22811622/):

Clinical Features:

• Progressive neurodegeneration: Characteristic brain lesions
• Developmental regression: Loss of achieved milestones
• Characteristic MRI findings: T2-hyperintense lesions in basal ganglia
• Lactic acidosis: Elevated blood and CSF lactate

• Autosomal recessive
• Both alleles must carry pathogenic variants

Mitochondrial Complex I Deficiency

Isolated complex I deficiency is the most common OXPHOS disorder [[vanbeerendonk2016]](https://pubmed.ncbi.nlm.nih.gov/26876724/):

• Phenotypes: Encephalomyopathy, cardiomyopathy, lactic acidosis
• NDUFS5 mutations: 15 kDa subunit deficiency [[loeffen2001]](https://pubmed.ncbi.nlm.nih.gov/11298655/)
• NDUFS5 variants: Null alleles cause severe disease
• Residual activity: Correlates with phenotype severity

Expression Patterns

Tissue Distribution

NDUFS5 is ubiquitously expressed:

• Brain: Highest in high-energy demand regions
• Heart: Very high expression in cardiac muscle
• Skeletal muscle: High expression for contractile function
• Kidney and liver: Moderate expression
• All tissues: Essential for cellular energy

Brain Regional Expression

NDUFS5 shows regional specificity:

• Substantia nigra: Dopaminergic neurons (vulnerable in PD)
• Cerebral cortex: Pyramidal neurons
• Hippocampus: CA1-CA3 neurons, dentate gyrus
• Cerebellum: Purkinje cells
• Brainstem: Motor neurons

Cell-Type Specific Expression

• Neurons: High expression, especially projection neurons
• Astrocytes: Supporting metabolic functions
• Oligodendrocytes: Myelination energy demands
• Microglia: Activity-dependent regulation

Regulatory Mechanisms

NDUFS5 expression is regulated by [[chen2015]](https://pubmed.ncbi.nlm.nih.gov/25766133/):

• Nuclear respiratory factors (NRF-1, NRF-2): Transcriptional activation
• PGC-1α: Master regulator of mitochondrial biogenesis
• ERRα: Estrogen-related receptor alpha
• NAD+/SIRT1 axis: Metabolic sensing

Therapeutic Implications

Current Therapeutic Strategies

Symptomatic Treatments:

• Coenzyme Q10 (100-300 mg/day)
• L-carnitine
• Creatine monohydrate
• Alpha-lipoic acid

• Nicotinamide riboside (NAD+ precursor)
• Mitochondria-targeted antioxidants (MitoQ)
• Gene replacement therapy
• Stem cell transplantation [[pitce2014]](https://pubmed.ncbi.nlm.nih.gov/24918344/)

Drug Development Targets

• Complex I activators: Enhance assembly and function
• Assembly chaperones: Promote proper complex I formation
• mTOR inhibitors: Activate mitophagy
• Metabolic modulators: Improve substrate utilization

Research Applications

• iPSC models: Patient-derived neurons for study
• Gene editing: CRISPR for mutation correction
• Drug screening: High-throughput compound libraries
• Biomarkers: Complex I activity as progression marker

Interactions and Pathways

Protein Interactions

• Core complex I subunits: ND1, ND2, ND3, etc.
• NDUFAF1: Assembly factor
• NDUFAF2: Molecular chaperone
• NDUFAF4: Early assembly factor

Mitochondrial Network

• Mitochondrial dynamics: Fusion/fission balance
• Mitophagy: PINK1/Parkin-mediated clearance
• Mitochondrial DNA: Dependent on nuclear-encoded subunits
• ATP synthase: Downstream OXPHOS component

Signaling Pathways

• mTOR signaling: Energy sensing
• AMPK pathway: Metabolic regulation
• SIRT1/NAD+ pathway: Metabolic sensing
• 凋亡途径: Apoptotic cascade activation

Molecular Mechanism

Assembly Pathway

Complex I assembly follows an ordered pathway:

NDUFS5 integrates into the Q module early in assembly:

• Pre-assembled subcomplex: Q-module precursor
• NDUFS5 incorporation: 15 kDa subunit addition
• Fe-S cluster transfer: [4Fe-4S] cluster insertion
• Completion: Functional complex I formation

Electron Transfer Chain

Within complex I, electrons flow:

NDUFS5 contributes to this pathway by:

• Stabilizing the Q-binding pocket
• Maintaining Fe-S cluster integrity
• Ensuring proper electron flow

Disease Models

Cellular Models

• Patient fibroblasts: For biochemical studies
• iPSC-derived neurons: Disease modeling
• Cybrid cell lines: mtDNA transfer studies
• Knockdown models: siRNA-mediated deficiency

Animal Models

• Zebrafish: Transparent for imaging
• Drosophila: Genetic tractability
• Mouse models: Mammalian physiology
• Conditional knockouts: Tissue-specific

Biochemical Studies

• Blue-native PAGE: Complex I activity assays
• Spectrophotometry: Enzyme kinetics
• Oxygraphy: Oxygen consumption
• Mitochondrial respirometry: Seahorse analysis

Clinical Significance

Diagnosis

• Genetic testing: Panel or whole-exome sequencing
• Biochemical testing: Complex I activity in muscle
• Neuroimaging: MRI for Leigh syndrome lesions
• Metabolic testing: Lactate, pyruvate levels

Prognosis

Complex I deficiency prognosis:

• Infantile onset: Most severe prognosis
• Late-onset: Variable progression
• Treatment response: Correlates with residual activity

Genetic Counseling

• Autosomal recessive: 25% recurrence risk
• Carrier testing: For at-risk family members
• Prenatal diagnosis: For known mutations
• Preimplantation: For carrier families

Research Directions

Recent Advances

• Atomic structure: Cryo-EM structures of complex I
• Assembly factors: Multiple chaperones identified
• Therapeutic targets: New drug candidates
• Gene therapy: Viral vector delivery

Future Directions

• Precise gene editing: CRISPR base editors
• Protein replacement: Encapsulated enzyme delivery
• Mitochondrial replacement: spindle transfer
• Combination therapies: Multi-target approaches

Cross-links

• [Complex I Protein](/proteins/complex-i-protein) - Corresponding protein page
• [Mitochondrial Complex I](/mechanisms/mitochondrial-complex-i) - Related pathway
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) - Related mechanism
• [Parkinson's Disease](/diseases/parkinsons-disease) - Disease association
• [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease association

References

See Also

• [Mitochondrial Complex I](/mechanisms/mitochondrial-complex-i)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Leigh Syndrome](/diseases/leigh-syndrome)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Genes - Index of gene pages](/genes)
• [Proteins - Index of protein pages](/proteins)

Pathway Diagram

The following diagram shows the key molecular relationships involving NDUFS5 — NADH:Ubiquinone Oxidoreductase Core Subunit S5 discovered through SciDEX knowledge graph analysis: